CLINICAL_TRIALS
trial_result
· 2015-08-10
Clinical Trial Update: A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267) [Phase 2]
Summary
Phase 2 clinical trial evaluating oral posaconazole for asymptomatic chronic Chagas disease has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Chagas Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-08-10